Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation LtdfiledCriticalWellcome Foundation Ltd
Publication of ES262655A1publicationCriticalpatent/ES262655A1/es
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K39/00—Medicinal preparations containing antigens or antibodies
A61K39/02—Bacterial antigens
A61K39/08—Clostridium, e.g. Clostridium tetani
Landscapes
Health & Medical Sciences
(AREA)
Life Sciences & Earth Sciences
(AREA)
Chemical & Material Sciences
(AREA)
Immunology
(AREA)
Medicinal Chemistry
(AREA)
Microbiology
(AREA)
Mycology
(AREA)
Pharmacology & Pharmacy
(AREA)
Epidemiology
(AREA)
Animal Behavior & Ethology
(AREA)
General Health & Medical Sciences
(AREA)
Public Health
(AREA)
Veterinary Medicine
(AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Peptides Or Proteins
(AREA)
Abstract
Mejoras introducidas en la preparación de vacunas que contienen beta-toxoide de Clostridium Perfringens, caracterizadas porque se ha eliminado de las mismas la mayor parte o la totalidad del formaldehído libre.
ES0262655A1959-11-231960-11-22Mejoras introducidas en la preparaciën de vacunas
ExpiredES262655A1
(es)
Fremgangsmåde til fremstilling af additionspolymere af umættede dicarboxylsyremonoestere af N-(hydroxyalkyl)- eller N-(hydroxylalkyl-oxyalkyl)-1,3-cyclodiazolidin-2-oner.